296 related articles for article (PubMed ID: 26713055)
21. Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
Patel BV; Remigio-Baker RA; Thiebaud P; Preblick R; Plauschinat C
BMC Fam Pract; 2008 Nov; 9():61. PubMed ID: 18990240
[TBL] [Abstract][Full Text] [Related]
22. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
[TBL] [Abstract][Full Text] [Related]
23. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
[TBL] [Abstract][Full Text] [Related]
24. Renin-Angiotensin-Aldosterone System-based Antihypertensive Agents and the Risk of Colorectal Cancer Among Medicare Beneficiaries.
Htoo PT; Stürmer T; Jonsson-Funk M; Pate V; Simpson RJ; Lund JL
Epidemiology; 2019 Nov; 30(6):867-875. PubMed ID: 31348009
[TBL] [Abstract][Full Text] [Related]
25. Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation?
Sonawane KB; Qian J; Garza KB; Wright BM; Zeng P; Ganduglia-Cazaban CM; Hansen RA
J Hypertens; 2016 Mar; 34(3):548-57; discussion 557. PubMed ID: 26820480
[TBL] [Abstract][Full Text] [Related]
26. Combination antihypertensive therapy among patients with COPD.
Herrin MA; Feemster LC; Crothers K; Uman JE; Bryson CL; Au DH
Chest; 2013 May; 143(5):1312-1320. PubMed ID: 23287970
[TBL] [Abstract][Full Text] [Related]
27. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
Doege C; Luedde M; Kostev K
JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.
Osula D; Wu B; Schesing K; Das SR; Moss E; Alvarez K; Clark C; Halm EA; Brown NJ; Vongpatanasin W
J Am Heart Assoc; 2022 Oct; 11(19):e027099. PubMed ID: 36193931
[TBL] [Abstract][Full Text] [Related]
29. Self-Reported Antihypertensive Medication Class and Temporal Relationship to Treatment Guidelines.
Egan BM; Yang J; Rakotz MK; Sutherland SE; Jamerson KA; Wright JT; Ferdinand KC; Wozniak GD
Hypertension; 2022 Feb; 79(2):338-348. PubMed ID: 34784722
[TBL] [Abstract][Full Text] [Related]
30. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
Brown A; Captain B
Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
[TBL] [Abstract][Full Text] [Related]
31. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
[TBL] [Abstract][Full Text] [Related]
32. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
Gadzhanova S; Roughead EE; Bartlett LE
Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
[TBL] [Abstract][Full Text] [Related]
33. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
Lu Y; Van Zandt M; Liu Y; Li J; Wang X; Chen Y; Chen Z; Cho J; Dorajoo SR; Feng M; Hsu MH; Hsu JC; Iqbal U; Jonnagaddala J; Li YC; Liaw ST; Lim HS; Ngiam KY; Nguyen PA; Park RW; Pratt N; Reich C; Rhee SY; Sathappan SMK; Shin SJ; Tan HX; You SC; Zhang X; Krumholz HM; Suchard MA; Xu H
JAMA Netw Open; 2022 Mar; 5(3):e223877. PubMed ID: 35323951
[TBL] [Abstract][Full Text] [Related]
35. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.
Baggarly SA; Kemp RJ; Wang X; Magoun AD
Res Social Adm Pharm; 2014; 10(6):e99-e112. PubMed ID: 24731547
[TBL] [Abstract][Full Text] [Related]
37. Persistence with antihypertensive medication: Australia-wide experience, 2004-2006.
Simons LA; Ortiz M; Calcino G
Med J Aust; 2008 Feb; 188(4):224-7. PubMed ID: 18279129
[TBL] [Abstract][Full Text] [Related]
38. Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.
Lachaine J; Petrella RJ; Merikle E; Ali F
Can J Cardiol; 2008 Apr; 24(4):269-73. PubMed ID: 18401466
[TBL] [Abstract][Full Text] [Related]
39. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.
Burke TA; Sturkenboom MC; Lu SE; Wentworth CE; Lin Y; Rhoads GG
J Hypertens; 2006 Jun; 24(6):1193-200. PubMed ID: 16685222
[TBL] [Abstract][Full Text] [Related]
40. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
Hiroi S; Shimasaki Y; Kikuchi T; Otsuka Y; Iwasaki K; Ohishi M
Hypertens Res; 2016 Dec; 39(12):907-912. PubMed ID: 27465576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
